{"id":3882,"date":"2026-06-07T06:47:46","date_gmt":"2026-06-07T13:47:46","guid":{"rendered":"https:\/\/xpharma.com.cn\/?p=3882"},"modified":"2026-06-07T06:47:47","modified_gmt":"2026-06-07T13:47:47","slug":"yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s","status":"publish","type":"post","link":"https:\/\/xpharma.com.cn\/index.php\/news\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\/","title":{"rendered":"Yunnan Baiyao: INB301 Receives FDA Clearance for Clinical Trials in the U.S."},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">On June 3, Yunnan Baiyao announced that its Investigational New Drug (IND) application for INB301 Injection has received clearance from the U.S. Food and Drug Administration (FDA) to conduct clinical trials, with the proposed indication being cancer cachexia. According to the announcement, this is the first therapeutic biologic innovative drug developed by Yunnan Baiyao. On April 27, 2026, Yunnan Baiyao submitted the IND application for INB301 to the U.S. FDA. On June 2, 2026, INB301 received clinical trial clearance.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Previously, the IND application for INB301 was formally accepted by China&#8217;s NMPA on February 24, 2026, was included in the 30-day fast-track review and approval channel for innovative drugs, and subsequently received clinical trial approval on March 30, 2026.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Buy INB301\u00a0online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>On June 3, Yunnan Baiyao announced that its Investigational New Drug (IND) application for INB301 Injection has received clearance from the U.S. Food and Drug Administration (FDA) to conduct clinical trials, with the proposed indication being cancer cachexia. According to the announcement, this is the first therapeutic biologic innovative drug developed by Yunnan Baiyao. On [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":3887,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[],"class_list":["post-3882","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Yunnan Baiyao: INB301 Receives FDA Clearance for Clinical Trials in the U.S. - Xpharma China<\/title>\n<meta name=\"description\" content=\"Yunnan Baiyao: INB301 Receives FDA Clearance for Clinical Trials in the U.S. - Xpharma China\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/xpharma.com.cn\/index.php\/news\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Yunnan Baiyao: INB301 Receives FDA Clearance for Clinical Trials in the U.S. - Xpharma China\" \/>\n<meta property=\"og:description\" content=\"Yunnan Baiyao: INB301 Receives FDA Clearance for Clinical Trials in the U.S. - Xpharma China\" \/>\n<meta property=\"og:url\" content=\"https:\/\/xpharma.com.cn\/index.php\/news\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\/\" \/>\n<meta property=\"og:site_name\" content=\"Xpharma China\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/61590027634719\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-07T13:47:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-07T13:47:47+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/06\/\u5fae\u4fe1\u56fe\u7247_2026-06-07_214337_759-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"463\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"xpharmanews\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Xpharma007\" \/>\n<meta name=\"twitter:site\" content=\"@Xpharma007\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"xpharmanews\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\\\/\"},\"author\":{\"name\":\"xpharmanews\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#\\\/schema\\\/person\\\/c292b26c0a3311036ce0f5ab28a1ea05\"},\"headline\":\"Yunnan Baiyao: INB301 Receives FDA Clearance for Clinical Trials in the U.S.\",\"datePublished\":\"2026-06-07T13:47:46+00:00\",\"dateModified\":\"2026-06-07T13:47:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\\\/\"},\"wordCount\":158,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/\u5fae\u4fe1\u56fe\u7247_2026-06-07_214337_759-1.jpg\",\"articleSection\":[\"Approved News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\\\/#respond\"]}]},{\"@type\":[\"WebPage\",\"MedicalWebPage\"],\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\\\/\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\\\/\",\"name\":\"Yunnan Baiyao: INB301 Receives FDA Clearance for Clinical Trials in the U.S. - Xpharma China\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/\u5fae\u4fe1\u56fe\u7247_2026-06-07_214337_759-1.jpg\",\"datePublished\":\"2026-06-07T13:47:46+00:00\",\"dateModified\":\"2026-06-07T13:47:47+00:00\",\"description\":\"Yunnan Baiyao: INB301 Receives FDA Clearance for Clinical Trials in the U.S. - Xpharma China\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\\\/#primaryimage\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/\u5fae\u4fe1\u56fe\u7247_2026-06-07_214337_759-1.jpg\",\"contentUrl\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/\u5fae\u4fe1\u56fe\u7247_2026-06-07_214337_759-1.jpg\",\"width\":640,\"height\":463,\"caption\":\"Yunnan Baiyao\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9875\",\"item\":\"https:\\\/\\\/xpharma.com.cn\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Yunnan Baiyao: INB301 Receives FDA Clearance for Clinical Trials in the U.S.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#website\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/\",\"name\":\"Xpharma China - International Pharmaceutical wholesaler and retailer\",\"description\":\"Xpharma China\",\"publisher\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/xpharma.com.cn\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#organization\",\"name\":\"Xpharma China\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/logo.gif\",\"contentUrl\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/logo.gif\",\"width\":679,\"height\":166,\"caption\":\"Xpharma China\"},\"image\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/61590027634719\\\/\",\"https:\\\/\\\/x.com\\\/Xpharma007\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#\\\/schema\\\/person\\\/c292b26c0a3311036ce0f5ab28a1ea05\",\"name\":\"xpharmanews\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g\",\"caption\":\"xpharmanews\"},\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/author\\\/xpharmanews\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Yunnan Baiyao: INB301 Receives FDA Clearance for Clinical Trials in the U.S. - Xpharma China","description":"Yunnan Baiyao: INB301 Receives FDA Clearance for Clinical Trials in the U.S. - Xpharma China","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/xpharma.com.cn\/index.php\/news\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\/","og_locale":"en_US","og_type":"article","og_title":"Yunnan Baiyao: INB301 Receives FDA Clearance for Clinical Trials in the U.S. - Xpharma China","og_description":"Yunnan Baiyao: INB301 Receives FDA Clearance for Clinical Trials in the U.S. - Xpharma China","og_url":"https:\/\/xpharma.com.cn\/index.php\/news\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\/","og_site_name":"Xpharma China","article_publisher":"https:\/\/www.facebook.com\/61590027634719\/","article_published_time":"2026-06-07T13:47:46+00:00","article_modified_time":"2026-06-07T13:47:47+00:00","og_image":[{"width":640,"height":463,"url":"http:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/06\/\u5fae\u4fe1\u56fe\u7247_2026-06-07_214337_759-1.jpg","type":"image\/jpeg"}],"author":"xpharmanews","twitter_card":"summary_large_image","twitter_creator":"@Xpharma007","twitter_site":"@Xpharma007","twitter_misc":{"Written by":"xpharmanews","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/xpharma.com.cn\/index.php\/news\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\/#article","isPartOf":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\/"},"author":{"name":"xpharmanews","@id":"https:\/\/xpharma.com.cn\/#\/schema\/person\/c292b26c0a3311036ce0f5ab28a1ea05"},"headline":"Yunnan Baiyao: INB301 Receives FDA Clearance for Clinical Trials in the U.S.","datePublished":"2026-06-07T13:47:46+00:00","dateModified":"2026-06-07T13:47:47+00:00","mainEntityOfPage":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\/"},"wordCount":158,"commentCount":0,"publisher":{"@id":"https:\/\/xpharma.com.cn\/#organization"},"image":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\/#primaryimage"},"thumbnailUrl":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/06\/\u5fae\u4fe1\u56fe\u7247_2026-06-07_214337_759-1.jpg","articleSection":["Approved News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/xpharma.com.cn\/index.php\/news\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\/#respond"]}]},{"@type":["WebPage","MedicalWebPage"],"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\/","url":"https:\/\/xpharma.com.cn\/index.php\/news\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\/","name":"Yunnan Baiyao: INB301 Receives FDA Clearance for Clinical Trials in the U.S. - Xpharma China","isPartOf":{"@id":"https:\/\/xpharma.com.cn\/#website"},"primaryImageOfPage":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\/#primaryimage"},"image":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\/#primaryimage"},"thumbnailUrl":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/06\/\u5fae\u4fe1\u56fe\u7247_2026-06-07_214337_759-1.jpg","datePublished":"2026-06-07T13:47:46+00:00","dateModified":"2026-06-07T13:47:47+00:00","description":"Yunnan Baiyao: INB301 Receives FDA Clearance for Clinical Trials in the U.S. - Xpharma China","breadcrumb":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/xpharma.com.cn\/index.php\/news\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/xpharma.com.cn\/index.php\/news\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\/#primaryimage","url":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/06\/\u5fae\u4fe1\u56fe\u7247_2026-06-07_214337_759-1.jpg","contentUrl":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/06\/\u5fae\u4fe1\u56fe\u7247_2026-06-07_214337_759-1.jpg","width":640,"height":463,"caption":"Yunnan Baiyao"},{"@type":"BreadcrumbList","@id":"https:\/\/xpharma.com.cn\/index.php\/news\/yunnan-baiyao-inb301-receives-fda-clearance-for-clinical-trials-in-the-u-s\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9875","item":"https:\/\/xpharma.com.cn\/"},{"@type":"ListItem","position":2,"name":"Yunnan Baiyao: INB301 Receives FDA Clearance for Clinical Trials in the U.S."}]},{"@type":"WebSite","@id":"https:\/\/xpharma.com.cn\/#website","url":"https:\/\/xpharma.com.cn\/","name":"Xpharma China - International Pharmaceutical wholesaler and retailer","description":"Xpharma China","publisher":{"@id":"https:\/\/xpharma.com.cn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/xpharma.com.cn\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/xpharma.com.cn\/#organization","name":"Xpharma China","url":"https:\/\/xpharma.com.cn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/xpharma.com.cn\/#\/schema\/logo\/image\/","url":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/04\/logo.gif","contentUrl":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/04\/logo.gif","width":679,"height":166,"caption":"Xpharma China"},"image":{"@id":"https:\/\/xpharma.com.cn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/61590027634719\/","https:\/\/x.com\/Xpharma007"]},{"@type":"Person","@id":"https:\/\/xpharma.com.cn\/#\/schema\/person\/c292b26c0a3311036ce0f5ab28a1ea05","name":"xpharmanews","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g","caption":"xpharmanews"},"url":"https:\/\/xpharma.com.cn\/index.php\/author\/xpharmanews\/"}]}},"_links":{"self":[{"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/posts\/3882","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/comments?post=3882"}],"version-history":[{"count":1,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/posts\/3882\/revisions"}],"predecessor-version":[{"id":3889,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/posts\/3882\/revisions\/3889"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/media\/3887"}],"wp:attachment":[{"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/media?parent=3882"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/categories?post=3882"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/tags?post=3882"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}